• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Preserflo微分流器植入后合并房水错流和持续性脉络膜积液

Combined aqueous misdirection and persistent choroidal effusions following implantation of a Preserflo MicroShunt.

作者信息

Malick Huzaifa, Wilde Craig, Stead Richard E

机构信息

University Hospitals of Leicester, Leicester Royal Infirmary, Infirmary Square, Leicester, LE1 5WW, 03003031573, United Kingdom.

Queens Medical Centre, Derby Road, Nottingham NG7 2UH, United Kingdom.

出版信息

Int J Ophthalmol. 2023 Apr 18;16(4):652-655. doi: 10.18240/ijo.2023.04.21. eCollection 2023.

DOI:10.18240/ijo.2023.04.21
PMID:37077484
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10089895/
Abstract

AIM

To describe a case of aqueous misdirection complicated by subsequent persistent choroidal effusions following implantation of a Preserflo MicroShunt (PMS) device to treat advanced closed angle glaucoma.

METHODS

A 67-year-old caucasian female with advanced primary angle-closure glaucoma on four medications with an intraocular pressure (IOP) of 26 mm Hg was listed for a PMS insertion with mitomycin C (MMC).

RESULTS

Past ocular history was significant for pseudophakia and previous yttrium aluminum garnet (YAG) peripheral iridotomy. Surgery was uneventful but on the first postoperative day, she developed aqueous misdirection complicated by subsequent development of persistent uveal effusions. Conventional treatment strategies including atropine drops, YAG hyaloidotomy and choroidal effusion drainage proved ineffective. A combination of oral steroids and pars plana vitrectomy (PPV) along with an irido-zonulo-hyloidectomy (IZH) proved efficacious.

CONCLUSION

To the best of the author's knowledge, this is the first published case of aqueous misdirection complicated with the presence of significant, unresolving choroidal effusions, highlighting the possibility and sequelae of comorbid pathology in nanophthalmic eyes.

摘要

目的

描述一例在植入Preserflo微型分流器(PMS)治疗晚期闭角型青光眼后发生房水错流并伴有持续性脉络膜积液的病例。

方法

一名67岁患有晚期原发性闭角型青光眼的白种女性,正在使用四种药物治疗,眼压(IOP)为26 mmHg,计划接受PMS植入并联合丝裂霉素C(MMC)治疗。

结果

既往眼部病史包括人工晶状体植入和既往钇铝石榴石(YAG)周边虹膜切开术。手术过程顺利,但术后第一天,她出现了房水错流,并随后出现了持续性葡萄膜积液。包括阿托品滴眼液、YAG玻璃体切割术和脉络膜积液引流在内的传统治疗策略均无效。口服类固醇、玻璃体切除术(PPV)联合虹膜-悬韧带-玻璃体切除术(IZH)的联合治疗被证明是有效的。

结论

据作者所知,这是首例发表的房水错流合并严重且持续不消退的脉络膜积液的病例,突出了小眼球合并病理状况的可能性和后遗症。

相似文献

1
Combined aqueous misdirection and persistent choroidal effusions following implantation of a Preserflo MicroShunt.Preserflo微分流器植入后合并房水错流和持续性脉络膜积液
Int J Ophthalmol. 2023 Apr 18;16(4):652-655. doi: 10.18240/ijo.2023.04.21. eCollection 2023.
2
A case of malignant glaucoma following insertion of Preserflo™ MicroShunt.Preserflo™ 微分流器植入术后发生恶性青光眼1例。
Eur J Ophthalmol. 2022 Jul;32(4):NP115-NP119. doi: 10.1177/11206721211003492. Epub 2021 Mar 18.
3
A Case of Delayed-onset Hemorrhagic Choroidal Detachment After PreserFlo Microshunt Implantation in a Glaucoma Patient Under Anticoagulant Therapy.抗凝血治疗的青光眼患者行 PreserFlo 微导管植入术后迟发性出血性脉络膜脱离 1 例
J Glaucoma. 2020 Aug;29(8):e87-e90. doi: 10.1097/IJG.0000000000001584.
4
Aqueous misdirection after glaucoma drainage device implantation.青光眼引流装置植入术后的房水错流
Ophthalmology. 1999 May;106(5):1035-40. doi: 10.1016/S0161-6420(99)00530-8.
5
Successful Management of Malignant Glaucoma With Irido-Zonulo-Hyaloidotomy and Complete Pars Plana Vitrectomy.虹膜-悬韧带-玻璃体前界膜切开术联合完全性玻璃体切割术成功治疗恶性青光眼
Cureus. 2022 Jan 28;14(1):e21679. doi: 10.7759/cureus.21679. eCollection 2022 Jan.
6
Successful Pars Plana Vitrectomy with Zonulo-hyaloidectomy Performed 4 Years after the Onset of Chronic Low-Grade Aqueous Misdirection.慢性低分级持续性水性迷路术后 4 年行板层巩膜切开伴虹膜睫状体松解术的玻璃体切除术成功。
Middle East Afr J Ophthalmol. 2021 Sep 25;28(2):137-139. doi: 10.4103/meajo.meajo_19_21. eCollection 2021 Apr-Jun.
7
Evaluation of the efficacy and safety of pars plana vitrectomy with irido-zonulo-hyaloidotomy for malignant glaucoma.评价睫状体平坦部玻璃体切割联合虹膜-悬韧带-睫状体光凝术治疗恶性青光眼的疗效和安全性。
J Fr Ophtalmol. 2024 Jan;47(1):103963. doi: 10.1016/j.jfo.2023.03.044. Epub 2023 Sep 28.
8
Late-onset Relapse of Aqueous Misdirection after Pars Plana Vitrectomy: Case Report and Literature Review.玻璃体切割术后迟发性房水错流复发:病例报告及文献综述
J Curr Glaucoma Pract. 2023 Jan-Mar;17(1):49-51. doi: 10.5005/jp-journals-10078-1397.
9
Pars plana vitrectomy combined with irido-zonulo-hyaloidectomy for aqueous misdirection.玻璃体切割联合虹膜-悬韧带-玻璃体切除术治疗房水错流
Eur J Ophthalmol. 2020 Mar;30(2):396-398. doi: 10.1177/1120672119872056. Epub 2019 Aug 29.
10
Aqueous misdirection after Nd:YAG goniopuncture in deep sclerectomy treated with Nd:YAG irido-zonulo-hyaloidotomy.Nd:YAG 后房角穿刺治疗深层巩膜切除术所致房水引流异常的 Nd:YAG 虹膜-睫状体-玻璃体内切开术。
Eur J Ophthalmol. 2022 Nov;32(6):NP28-NP31. doi: 10.1177/11206721211019556. Epub 2021 May 20.

引用本文的文献

1
Acute fluid misdirection syndrome in intraocular collamer lens implantation: a case report and review of literature.人工晶状体植入术中急性液体错流综合征:一例报告并文献复习
BMC Ophthalmol. 2025 Aug 18;25(1):473. doi: 10.1186/s12886-025-04298-z.

本文引用的文献

1
PRESERFLO™ MicroShunt versus trabeculectomy: first results on efficacy and safety.PRESERFLO™微型分流器与小梁切除术:疗效和安全性的初步结果
Acta Ophthalmol. 2022 May;100(3):e779-e790. doi: 10.1111/aos.14968. Epub 2021 Jul 31.
2
A case of malignant glaucoma following insertion of Preserflo™ MicroShunt.Preserflo™ 微分流器植入术后发生恶性青光眼1例。
Eur J Ophthalmol. 2022 Jul;32(4):NP115-NP119. doi: 10.1177/11206721211003492. Epub 2021 Mar 18.
3
Ab externo implantation of the MicroShunt, a poly (styrene--isobutylene--styrene) surgical device for the treatment of primary open-angle glaucoma: a review.用于治疗原发性开角型青光眼的聚(苯乙烯-异丁烯-苯乙烯)手术装置MicroShunt的外部植入:综述
Eye Vis (Lond). 2019 Nov 15;6:36. doi: 10.1186/s40662-019-0162-1. eCollection 2019.
4
Three-Year Follow-up of a Novel Aqueous Humor MicroShunt.新型房水微分流器的三年随访
J Glaucoma. 2016 Feb;25(2):e58-65. doi: 10.1097/IJG.0000000000000368.
5
Postoperative complications in the Tube Versus Trabeculectomy (TVT) study during five years of follow-up.术后五年随访中 Tube Versus Trabeculectomy(TVT)研究中的并发症。
Am J Ophthalmol. 2012 May;153(5):804-814.e1. doi: 10.1016/j.ajo.2011.10.024. Epub 2012 Jan 14.
6
Outcomes of different management options for malignant glaucoma: a retrospective study.不同恶性青光眼处理方法的结局:一项回顾性研究。
Graefes Arch Clin Exp Ophthalmol. 2012 Jan;250(1):131-41. doi: 10.1007/s00417-011-1763-0. Epub 2011 Aug 20.
7
Mydriatic-cycloplegic treatment in malignant glaucoma.恶性青光眼的散瞳睫状肌麻痹治疗
Arch Ophthalmol. 1962 Sep;68:353-9. doi: 10.1001/archopht.1962.00960030357010.
8
The role of vitreous detachment in aphakic and malignant glaucoma.玻璃体脱离在无晶状体性青光眼和恶性青光眼中的作用。
Trans Am Acad Ophthalmol Otolaryngol. 1954 Mar-Apr;58(2):217-31.
9
Possible mechanisms of primary angle-closure and malignant glaucoma.原发性闭角型青光眼和恶性青光眼的可能机制。
J Glaucoma. 2003 Apr;12(2):167-80. doi: 10.1097/00061198-200304000-00013.
10
Malignant glaucoma. Medical and surgical treatment.恶性青光眼。药物及手术治疗。
Am J Ophthalmol. 1968 Sep;66(3):495-502.